Private Prostate Cancer Screening in the UK: Costs & Tests 

Private prostate cancer screening means choosing and paying for checks that look for early signs of prostate cancer outside the NHS. Most people start with a PSA blood test, sometimes alongside a digital rectal examination (DRE). Depending on your age, risk and results, you may be offered a multiparametric MRI (mpMRI) and, in some clinics, advanced biomarkers to refine risk. The goal is to spot clinically significant cancers early while reducing unnecessary biopsies—but screening can bring false alarms, extra tests and, occasionally, overdiagnosis. A normal result also doesn’t remove future risk.

This guide explains who private screening is for, the tests used and how they fit together, how private options compare with the NHS, benefits and drawbacks, typical UK costs, and how to book—whether in a clinic, hospital or via an at-home kit. You’ll also learn how to prepare, understand results, when MRI or biopsy is advised, sensible screening intervals, how to choose a trustworthy provider, and where to access expert care in London.

Who private prostate screening is for in the UK

Private prostate cancer screening suits anyone who wants rapid access, clear next steps and continuity with a specialist. It’s appropriate for men and for some non-binary, intersex and transgender people who have a prostate; for those with urinary changes or anxiety about risk; for people with a previously raised or borderline PSA or an abnormal DRE; and for anyone seeking a baseline test, a second opinion, or a more comprehensive pathway (PSA, mpMRI and consultant review) without delay.

The main tests used in private screening (PSA, DRE, mpMRI and advanced biomarkers)

Private prostate cancer screening typically starts with a PSA blood test and a digital rectal examination (DRE). Depending on your PSA level, examination and personal risk, you may be offered a multiparametric MRI (mpMRI). Some clinics add advanced biomarkers to refine risk before deciding on further tests.

• PSA blood test: Measures prostate-specific antigen in the blood. It’s quick and widely available as a stand‑alone test or within private assessments. Levels can rise for reasons other than cancer, so context and follow‑up are vital.
• Digital rectal examination (DRE): A brief, gloved‑finger exam to assess prostate size, shape and any irregularities that might warrant further investigation.
• mpMRI scan: A detailed, non‑invasive scan of the prostate used to identify suspicious areas and guide next steps. Private centres offer mpMRI as part of screening pathways.
• Advanced biomarkers: Selectively used tests to improve risk stratification, such as the PCA3 urine gene test (performed after prostate examination) and the Stockholm3 blood test offered by some providers. These are not first‑line for everyone and are chosen based on symptoms, PSA and clinical judgement.

How private screening compares with NHS options

In the UK, you can pursue prostate checks privately or start via your GP. Private prostate cancer screening offers direct booking for PSA, DRE and mpMRI, with some providers also offering advanced biomarkers (for example PCA3 urine testing and Stockholm3) and at‑home PSA kits. Through your GP, you can have a PSA test and, if needed, be referred to a consultant urologist who may recommend further tests such as mpMRI or PCA3. Private pathways often package consultations, imaging and add‑on biomarkers, while GP/NHS routes typically progress stepwise based on clinical need.

• Access: Self‑pay online booking vs GP assessment and referral.
• Tests available: PSA/DRE in both; private may add PCA3, Stockholm3 and mpMRI packages.
• Settings: Clinic, hospital or at‑home kit vs GP surgery and hospital clinics.
• Choice: Named consultant in private care vs assigned through referral.

Benefits and limitations to consider before you test

Private screening can deliver fast answers and a joined‑up pathway, but it still involves trade‑offs. Before booking, balance the potential advantages of earlier detection and tailored care with the reality that tests aren’t perfect and may lead to further investigations, costs and uncertainty.

• Early detection: Opportunity to identify clinically significant cancers before symptoms.
• Fewer unnecessary biopsies: mpMRI helps target suspicious areas and can avoid some biopsies.
• Personal choice: Pick your consultant, setting and whether to add biomarkers.
• PSA is non‑specific: Raised results can come from non‑cancer causes and trigger more tests.
• False alarms and overdiagnosis: May lead to anxiety, extra scans or procedures.
• Costs add up: Self‑pay tests and any follow‑up can increase total spend.
• Not one‑and‑done: A normal result doesn’t remove future risk; ongoing monitoring is sensible.

How much private prostate cancer screening costs in the UK

Prices vary by provider and what’s included. You can self-pay for a stand‑alone PSA blood test through private hospitals or pharmacies, and some offer simple at‑home blood collection kits. Many patients choose bundled pathways that combine consultation, PSA/DRE and, where appropriate, mpMRI or advanced biomarkers; these packages make total costs clearer but follow‑on tests are usually billed separately.

• Screening package example: One London provider lists a prostate screening package at £650 including two consultant consultations, blood/urine tests and a physical exam.
• mpMRI package example: Some imaging centres offer a prostate MRI screening package priced at £650.
• PSA-only routes: Private hospitals allow online purchase of a PSA test; prices vary by site.
• Advanced biomarkers (PCA3, Stockholm3): Available at select clinics and typically charged in addition to core tests.
• Tip: Ask for an itemised quote and what happens (and costs) if further imaging or biopsy is recommended.

How to book: clinic appointment, hospital pathway or at-home kit

Booking private prostate cancer screening is simple: choose your route, confirm what’s included, and who will interpret your results and advise on next steps.

• Clinic appointment: Book directly with a consultant urologist for PSA/DRE and a same‑day plan; mpMRI is arranged if needed.
• Hospital pathway: Get a PSA (online or via your GP), then self‑pay for a hospital clinic that bundles consultation and tests, with mpMRI when appropriate.
• At‑home kit: Order an accredited PSA kit, post your sample, and ensure a clinician will review results and arrange follow‑up if raised.

How to prepare for a PSA test and other assessments

A little preparation helps make private prostate cancer screening more reliable and comfortable. You don’t need to fast for a PSA, but timing, recent activities and procedures can influence the result. For scans and biomarker tests, simple practical steps reduce delays and help your team give clear advice on next steps.

• Before a PSA: Avoid ejaculation and vigorous cycling for a couple of days; postpone testing if you have urinary infection symptoms or have recently had prostate procedures; tell your clinician about medicines like finasteride/dutasteride that lower PSA.
• On the day: Stay well hydrated, arrive on time, and bring previous results so trends can be assessed.
• For DRE/clinic review: No special prep; a relaxed pelvic floor helps.
• For mpMRI: Complete the safety questionnaire (implants, metal, claustrophobia), remove metal items, and discuss sedation if anxious.
• For urine/biomarker tests: Follow kit or clinic instructions exactly; you may be asked not to pass urine shortly beforehand.

Understanding your results and what happens next

Your results are never judged by a single number. An experienced urologist will weigh your PSA level and trend, age, prostate size, medicines, family history, ethnicity, DRE findings and, where done, mpMRI or biomarker results to estimate your personal risk and recommend the safest next step in your private prostate cancer screening pathway.

• Low risk/normal: Reassurance and a personalised recall plan for future PSA checks.
• Borderline or rising PSA: Repeat the test, address transient causes, consider mpMRI or selected biomarkers (e.g., PCA3, Stockholm3).
• Abnormal DRE or clearly raised PSA: Prioritise mpMRI; if suspicious, plan targeted biopsy.
• Negative imaging/low biomarkers: Monitoring rather than biopsy, with agreed intervals.
• Cancer confirmed: Full staging and a tailored plan, from active surveillance to curative treatment, with continuity under a named consultant.

MRI and biopsy: when they are used and modern techniques

In most private pathways, mpMRI comes after a raised or changing PSA, an abnormal DRE, or ongoing concern despite borderline results. The scan maps any suspicious areas and helps decide if a biopsy is necessary. If the MRI is reassuring and your overall risk is low, your consultant may suggest monitoring rather than immediate biopsy. If concern remains, biopsy is used to confirm or exclude clinically significant cancer.

• When MRI is used: Raised/borderline PSA, abnormal DRE, or concerning biomarker trends to refine risk and guide next steps.
• When biopsy is used: Suspicious MRI or persistently high clinical concern; sampling is targeted to MRI‑identified areas, often as a day‑case under local anaesthetic.

This MRI‑first, targeted approach aims to reduce unnecessary biopsies in private prostate cancer screening while focusing treatment where it matters.

Screening intervals and when to start based on your risk

In private prostate cancer screening, timing is personalised. Many people choose a baseline PSA in mid‑life, especially if they want rapid answers or have risk factors; some private at‑home kits are marketed from age 40. Your start point and recall interval then depend on your PSA trend, examination, mpMRI/biomarkers where used, family history and ethnicity, with a consultant setting a plan that balances vigilance with avoiding unnecessary tests.

• Average risk: Baseline PSA ± DRE, then periodic recall based on result and trend.
• Higher risk (e.g., strong family history, Black ethnicity, prior raised PSA): Consider an earlier start and closer monitoring.
• Low baseline and normal findings: Longer recall interval is often appropriate.
• Borderline or changing PSA: Short‑interval repeat and, if needed, mpMRI or selected biomarkers.
• Clearly raised PSA or abnormal DRE: Prioritise mpMRI now rather than waiting for the next routine check.

How to choose a private provider you can trust

Who you choose shapes speed, safety and clarity. Prefer a consultant‑led pathway that integrates PSA, DRE, mpMRI and selective biomarkers (e.g., PCA3, Stockholm3) with transparent pricing and documented follow‑up. Continuity with a named urologist, timely imaging, and clear escalation to biopsy when appropriate are hallmarks of a trustworthy private prostate screening service.

• Evidence‑based protocol: Tailored, not one‑size‑fits‑all.
• Specialist mpMRI reporting: Prostate‑focused radiology expertise.
• Transparent pricing: Itemised fees and next‑step costs.
• Rapid turnaround: Quick results and direct access.
• Biopsy capability & continuity: Targeted techniques, same consultant.
• Clinical oversight for at‑home PSA: Review plus arranged follow‑up.

Private prostate screening in London with Ashwin Sridhar

For private prostate cancer screening in London, you can see Mr Ashwin Sridhar, a Consultant Urological Surgeon specialising in prostate care and robotic surgery. He offers a discreet, consultant‑led pathway with rapid access: focused history, PSA and DRE, personalised risk assessment, and—when indicated—prompt mpMRI with clear next steps. If concern remains, he arranges targeted biopsy only when necessary and discusses all options from active surveillance to curative treatment. Whether it’s a baseline check, a raised PSA or a second opinion, you’ll have continuity with a named specialist throughout.

Conclusion

Private prostate cancer screening offers speed, clarity and a joined‑up plan when PSA, DRE, mpMRI and selective biomarkers are used thoughtfully. Use this guide to decide what to book, what it should cost, and how often to check. For discreet, consultant‑led screening in London with clear next steps, you can book private prostate screening with Ashwin Sridhar and get a personalised plan from first test to resolution.